vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是PHIBRO ANIMAL HEALTH CORP的1.1倍（$396.1M vs $373.9M），PHIBRO ANIMAL HEALTH CORP净利率更高（7.3% vs 4.7%，领先2.6%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 20.9%），PHIBRO ANIMAL HEALTH CORP自由现金流更多（$8.3M vs $-59.8M），过去两年PHIBRO ANIMAL HEALTH CORP的营收复合增速更高（19.2% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
CMP vs PAHC — 直观对比
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $373.9M |
| 净利润 | $18.6M | $27.5M |
| 毛利率 | 16.0% | 35.5% |
| 营业利润率 | 9.2% | 13.5% |
| 净利率 | 4.7% | 7.3% |
| 营收同比 | 28.9% | 20.9% |
| 净利润同比 | 178.8% | 762.1% |
| 每股收益（稀释后） | $0.43 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $396.1M | $373.9M | ||
| Q3 25 | $227.5M | $363.9M | ||
| Q2 25 | $214.6M | $378.7M | ||
| Q1 25 | $494.6M | $347.8M | ||
| Q4 24 | $307.2M | $309.3M | ||
| Q3 24 | $208.8M | $260.4M | ||
| Q2 24 | $202.9M | $273.2M | ||
| Q1 24 | $364.0M | $263.2M |
| Q4 25 | $18.6M | $27.5M | ||
| Q3 25 | $-7.2M | $26.5M | ||
| Q2 25 | $-17.0M | $17.2M | ||
| Q1 25 | $-32.0M | $20.9M | ||
| Q4 24 | $-23.6M | $3.2M | ||
| Q3 24 | $-48.3M | $7.0M | ||
| Q2 24 | $-43.6M | $752.0K | ||
| Q1 24 | $-38.9M | $8.4M |
| Q4 25 | 16.0% | 35.5% | ||
| Q3 25 | 16.9% | 32.9% | ||
| Q2 25 | 19.2% | 29.0% | ||
| Q1 25 | 15.5% | 30.1% | ||
| Q4 24 | 11.2% | 32.9% | ||
| Q3 24 | 9.3% | 32.1% | ||
| Q2 24 | 16.1% | 31.9% | ||
| Q1 24 | 19.7% | 30.2% |
| Q4 25 | 9.2% | 13.5% | ||
| Q3 25 | 5.3% | 14.1% | ||
| Q2 25 | 7.4% | 8.9% | ||
| Q1 25 | -0.6% | 9.6% | ||
| Q4 24 | 0.2% | 8.3% | ||
| Q3 24 | -14.3% | 6.8% | ||
| Q2 24 | 2.9% | 6.7% | ||
| Q1 24 | -10.8% | 7.6% |
| Q4 25 | 4.7% | 7.3% | ||
| Q3 25 | -3.2% | 7.3% | ||
| Q2 25 | -7.9% | 4.5% | ||
| Q1 25 | -6.5% | 6.0% | ||
| Q4 24 | -7.7% | 1.0% | ||
| Q3 24 | -23.1% | 2.7% | ||
| Q2 24 | -21.5% | 0.3% | ||
| Q1 24 | -10.7% | 3.2% |
| Q4 25 | $0.43 | $0.67 | ||
| Q3 25 | — | $0.65 | ||
| Q2 25 | $-0.41 | $0.43 | ||
| Q1 25 | $-0.77 | $0.51 | ||
| Q4 24 | $-0.57 | $0.08 | ||
| Q3 24 | $-1.17 | $0.17 | ||
| Q2 24 | $-1.05 | $0.02 | ||
| Q1 24 | $-0.94 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $74.5M |
| 总债务越低越好 | $890.0M | $624.2M |
| 股东权益账面价值 | $260.5M | $332.4M |
| 总资产 | $1.5B | $1.4B |
| 负债/权益比越低杠杆越低 | 3.42× | 1.88× |
8季度趋势，按日历期对齐
| Q4 25 | $46.7M | $74.5M | ||
| Q3 25 | $59.7M | $85.3M | ||
| Q2 25 | $79.4M | $77.0M | ||
| Q1 25 | $49.5M | $70.4M | ||
| Q4 24 | $45.8M | $67.1M | ||
| Q3 24 | $20.2M | $89.8M | ||
| Q2 24 | $12.8M | $114.6M | ||
| Q1 24 | $38.3M | $98.7M |
| Q4 25 | $890.0M | $624.2M | ||
| Q3 25 | $839.8M | $628.0M | ||
| Q2 25 | $833.4M | $631.7M | ||
| Q1 25 | $807.6M | $635.4M | ||
| Q4 24 | $974.4M | $639.1M | ||
| Q3 24 | $921.2M | $295.2M | ||
| Q2 24 | $875.1M | $312.1M | ||
| Q1 24 | $877.2M | — |
| Q4 25 | $260.5M | $332.4M | ||
| Q3 25 | $234.1M | $311.7M | ||
| Q2 25 | $249.8M | $285.7M | ||
| Q1 25 | $236.5M | $266.0M | ||
| Q4 24 | $263.0M | $246.8M | ||
| Q3 24 | $316.6M | $258.5M | ||
| Q2 24 | $352.1M | $256.6M | ||
| Q1 24 | $400.4M | $270.1M |
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.6B | $966.3M | ||
| Q2 24 | $1.6B | $982.2M | ||
| Q1 24 | $1.7B | $979.0M |
| Q4 25 | 3.42× | 1.88× | ||
| Q3 25 | 3.59× | 2.01× | ||
| Q2 25 | 3.34× | 2.21× | ||
| Q1 25 | 3.41× | 2.39× | ||
| Q4 24 | 3.70× | 2.59× | ||
| Q3 24 | 2.91× | 1.14× | ||
| Q2 24 | 2.49× | 1.22× | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $8.3M |
| 自由现金流率自由现金流/营收 | -15.1% | 2.2% |
| 资本支出强度资本支出/营收 | 5.8% | 3.0% |
| 现金转化率经营现金流/净利润 | -1.99× | 0.70× |
| 过去12个月自由现金流最近4个季度 | $94.1M | $47.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-37.0M | $19.4M | ||
| Q3 25 | $-6.9M | $9.3M | ||
| Q2 25 | $21.8M | $21.3M | ||
| Q1 25 | $186.9M | $43.2M | ||
| Q4 24 | $-4.1M | $3.1M | ||
| Q3 24 | $-12.7M | $12.6M | ||
| Q2 24 | $-6.8M | $28.4M | ||
| Q1 24 | $86.2M | $11.4M |
| Q4 25 | $-59.8M | $8.3M | ||
| Q3 25 | $-22.8M | $-4.5M | ||
| Q2 25 | $3.8M | $8.1M | ||
| Q1 25 | $172.9M | $35.4M | ||
| Q4 24 | $-25.9M | $-4.7M | ||
| Q3 24 | $-33.6M | $3.0M | ||
| Q2 24 | $-21.5M | $15.4M | ||
| Q1 24 | $56.2M | $1.7M |
| Q4 25 | -15.1% | 2.2% | ||
| Q3 25 | -10.0% | -1.2% | ||
| Q2 25 | 1.8% | 2.1% | ||
| Q1 25 | 35.0% | 10.2% | ||
| Q4 24 | -8.4% | -1.5% | ||
| Q3 24 | -16.1% | 1.2% | ||
| Q2 24 | -10.6% | 5.6% | ||
| Q1 24 | 15.4% | 0.6% |
| Q4 25 | 5.8% | 3.0% | ||
| Q3 25 | 7.0% | 3.8% | ||
| Q2 25 | 8.4% | 3.5% | ||
| Q1 25 | 2.8% | 2.2% | ||
| Q4 24 | 7.1% | 2.5% | ||
| Q3 24 | 10.0% | 3.7% | ||
| Q2 24 | 7.2% | 4.8% | ||
| Q1 24 | 8.2% | 3.7% |
| Q4 25 | -1.99× | 0.70× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 2.07× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.81× | ||
| Q2 24 | — | 37.80× | ||
| Q1 24 | — | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
